Monthly Archives: September 2015

Printed Circuit Board (PCB) Market size, Share, Analysis and Research Report: QYresearch Reports

New Market Research Reports Title “Printed Circuit Board (PCB) Market Research Report” Has Been Added to QYresearch Reports, Report database

For a detailed analysis of the overall outlook, the report brings in necessary information of Printed Circuit Board (PCB) Market consisting of description, categorization, application, chain structure of the industry, industry outlook, policy study, news study and so on.

For studying the markets of China and the world, the report examines the marketing trends of China and other areas or nations (like US, Europe, Japan, and so on). This is done by showing research studies on worldwide commodities of various kinds, advancements in applications, market developments, advanced equipments, economical backdrop and potential of the market. Research studies are also shown on the price of manufacture, cost, turnovers, value of manufacture and gross margin of 2009-2014’s dominating nations and participants.

For more details, visit:
http://www.qyresearchreports.biz/market-research/printed-circuit-board-pcb-market-research-report-2014

For participants dominating the market, relevant data is registered as commodities, clients, applications, potential, position in the market, and contact information of the company, etc. Prediction on the prospects, manufacture, price, cost, turnovers, value of manufacture and gross margin of these markets are also integrated.

For the detailed study of production plants and scientific data, the report studies and examines the Printed Circuit Board (PCB)’s market dominating participants on industrial date of manufacture, their potential, distribution of production plants, status of research and development, scientific sources and sources of unprocessed materials. This report also brings to the forefront the requirements of products, production procedures, price structure of the commodity, etc. Manufacturing is split further into technology, regions and applications. The study also envelops upstream unrefined materials, technology, the downstream study of clients, channels of marketing, trends of industrial growth and various plans.

Read more reports of this category at:
http://www.qyresearchreports.biz/market-research/category/ict

At the closing stages, the export is inclusive of the new project SWOT, investment viability, investment return and development studies of the Printed Circuit Board (PCB) market. Thus, this is an intense investigative report on the worldwide Printed Circuit Board (PCB) market. Here, we convey our thanks to the assistance received from the industrial specialists and sales engineers of the Printed Circuit Board (PCB) market while reviewing and interrogating the team of research.

Related Reports by QYresearch Reports

  • Scaling Powder Market:
    http://www.qyresearchreports.biz/market-research/scaling-powder-market-research-report-2014
    For studying the markets of China and the world, the report examines the marketing trends of China and other areas or nations (like US, Europe, Japan, and so on). This is done by showing research studies on worldwide commodities of various kinds, advancements in applications, market developments, advanced equipments, economical backdrop and potential of the market. Research studies are also shown on the price of manufacture, cost, turnovers, value of manufacture and gross margin of 2009-2014’s dominating nations and participants.
  • Service Robotics Market:
    http://www.qyresearchreports.biz/market-research/service-robotics-market-research-report-2014
    For the detailed study of production plants and scientific data, the report studies and examines the Service Robotics’s market dominating participants on industrial date of manufacture, their potential, distribution of production plants, status of research and development, scientific sources and sources of unprocessed materials. This report also brings to the forefront the requirements of products, production procedures, price structure of the commodity, etc. Manufacturing is split further into technology, regions and applications. The study also envelops upstream unrefined materials, technology, the downstream study of clients, channels of marketing, trends of industrial growth and various plans.


For More Information, Visit QYresearch Reports at:
http://www.qyresearchreports.biz/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/09/1443591556.jpeg

“QYresearch Reports”

Media Contact
Company Name: QYresearch Reports
Contact Person: Michelle Rogers
Email: sales@qyresearchreports.com
Phone: 1-800-489-3075
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.qyresearchreports.biz/market-research/printed-circuit-board-pcb-market-research-report-2014

Source: ABNewswire

ReleaseID: 38891

Global Coil Tubing Market Size, Growth, Trends & Forecast Report To 2022: Dniamericas

Dniamericas.com has announced the addition of “Global Coil Tubing Market Trends And Analysis Report By 2022” Market Research Report to their Database.

Global growth in oil & gas industry coupled with increased energy demand in Middle East & Africa (MEA) and Asian regions is expected to be a key driving factor for coil tubing market growth over the next seven years. Increase in shale gas projects coupled with new reserve discoveries is anticipated to prompt coil tubing market growth. Diverse coil tubing applications such as nitrogen pumping and well clean outs are expected to be the key factor further complementing coil tubing market growth over the forecast period. Coil tubing market can be classified under drilling services and well intervention services. Well intervention services are further segmented into well cleaning and well completion services. Various advantages of coil tubing such as reduced labor requirement, quicker trip times in oil & gas industry is slated to fuel coil tubing demand which in turn is expected to augment coil tubing market growth.

Ageing facilities in oil & gas is also expected to be a driver for coil tubing technology and thereby coil tubing market growth. Coil tubing market is anticipated to be poised for growth owing to channeled investments in exploration and production activities over the forecast period. Increasing demand for well services owing to aforementioned factors is expected to propel coil tubing demand thereby augmenting coil tubing market growth. Coil tubing market is expected to grow further owing to deep water drilling and offshore market development. Increased awareness about new and innovative technology such as coil tubing technology backed by investments is anticipated to prompt coil tubing demand which in turn is expected to augment coil tubing market growth over the forecast period.

Browse full research report with TOC on “Global Coil Tubing Market, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2015 To 2022″ at:
http://www.dniamericas.org/news/global-coil-tubing-market-market-size-application-analysis-regional-outlook-competitive-strategies-and-forecasts-2015-to-2022/

North America is expected to remain the dominant regional market and witness considerable growth over the forecast period owing to increased shale gas production in U.S coupled with favorable regulations. Increasing shale gas extraction in China is likely to have a positive impact on coil tubing market in Asia Pacific. Furthermore, Asia Pacific is expected to be a potential market and witness significant growth owing to increased investment in coil tubing technology. UAE, Saudi Arabia and Qatar are also expected to drive coil tubing market growth in Middle East owing to increased crude oil production over the forecast period.

Key players operating in coil tubing market include Superior Energy Services, Inc. Halliburton Co, Trican Well Services Ltd, Schlumberger Ltd, Calfrac Well Services Ltd and Baker Hughes, Inc.

Latest Report by Radiant Insights:


About Dniamericas

Dniamericas is the World’s first and heading home-made and free news hard and fast association. Completely robotized, and on a consistent initiate, redesigns breaking contrivances interfacing to news areas all around the globe. We work by matching breaking news articles, legitimately, against pressing word based subject determinations, passing on key relationship with clients, and material perusers to distributers.


For more information, visit http://www.dniamericas.org/

Media Contact
Company Name: Dniamericas
Contact Person: Michelle Rogers
Email: sales@dniamericas.org
Phone: 1-800-489-3075
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.dniamericas.org/news/global-coil-tubing-market-market-size-application-analysis-regional-outlook-competitive-strategies-and-forecasts-2015-to-2022/

Source: ABNewswire

ReleaseID: 38890

Bluedrop Performance Learning Grants Stock Options

ST. JOHN’S, NL / ACCESSWIRE / September 30, 2015 / Bluedrop Performance Learning Inc. (“Bluedrop”) (TSX-V: BPL) announces the granting of incentive stock options to certain directors, officers and employees to purchase up to 1,891,404 common shares under the Company’s Incentive Stock Option Plan. The options expire on September 30, 2020 and vest over a three year period as follows: 10% at time of grant; 20% on the first anniversary date; 20% on the second anniversary date and 50% on the third anniversary date. The options are exercisable at a price of $0.075 per share.

About Bluedrop

Bluedrop Performance Learning (TSX-V: BPL) is an innovator in workplace training for individuals, corporations, military personnel and the public sector. Bluedrop is transforming the workplace by designing, developing and delivering practical, actionable and affordable training content that improves individual and overall performance of organizations.

For more information, visit www.bluedrop.com.

Media contact:

Lynn Hammond
Bluedrop Performance Learning Inc.
lynnhammond@bluedrop.com
709-570-5691
709-330-1260

SOURCE: Bluedrop Performance Learning Inc.

ReleaseID: 432331

Worldwide March Against Extinction – This Weekend

With the possibility of extinction a reality within a generation, the world will march for elephants and rhinos this weekend. San Francisco marchers will call on Beijing to give the world a timeline for ending the ivory trade in their nation.

San Francisco, United States – September 30, 2015 /MarketersMedia/ —

Please join March for Elephants and Rhinos in San Francisco
Saturday, October 3, 2015
10:00 am – 3:00 PM
Starting at Jefferson Park Square | Rally at UN Plaza

Approximately one elephant is killed every 15 minutes in the African continent, 100 elephants are killed every day, 35,000 elephants are killed every year, 1 rhino is killed every 7-11 hours and extinction looms within a generation.

China is the world’s largest market for illegal ivory.

March for Elephants (MFE) will be joining over 130 other cities worldwide in marching and speaking out for elephants and rhinos on October 3rd 2015 in San Francisco. Marchers will gather around the Chinese consulate, engage in street theater and demand an end to the ivory trade in China, an end to the trade in the USA and an end to the trade anywhere ivory and rhino horn are commodified.

Recently, the Government of China has repeatedly pledged to end the domestic ivory trade in their nation; however, there has been no timeline specified. The earth’s last elephants and rhinos deserve a timeline. MFE calls on Beijing to provide the world with a timeline.

Wendie Wendt, Executive Director of ROCK THE ELEPHANT’®, Ed Stewart, President and Cofounder of PAWS-Performing Animal Welfare Society, Jamey Ponte, founding partner of KUAPO-Kenyans United Against Poaching and Board member of the Jane Goodall Institute and Toni Frohoff, scientist with IDA are among those who’ll take the stage at the rally. Last year, the San Francisco march and rally drew approximately 2,000 people.

MFE is a grassroots volunteer organization based in San Francisco working on behalf of earth’s last elephants and rhinos. They are a group of dedicated advocates, lobbying strategically to promote local and global awareness about the elephant and rhino crises, calling for governments to take immediate action to end poaching in range nations, and demanding an end to the ivory and rhino horn trade at all levels: locally, nationally and internationally.
You can help us by marching for elephants on October 3. Learn more by visiting March for Elephants.

Photo by Patrick Freeman

Event page on FB: https://www.facebook.com/events/1613044038927147/

For more information about us, please visit http://www.marchforelephants.org

Contact Info:
Name: Julie Callahan
Email: jcstars@earthlink.net
Organization: March for Elephants
Address:
Phone: 408-981-4134

Video URL: https://www.youtube.com/watch?v=fUsQgAt0smo

Source: http://marketersmedia.com/worldwide-march-against-extinction-this-weekend/92562

Release ID: 92562

Golmate Enterprise Limited to Attend the 2nd Phase of the Canton Fair

An industry leader in the manufacturing thermal ware is slated to attend one of China’s top import and export fairs in October.

Guangzhou, Guangdong, China – September 30, 2015 /MarketersMedia/ —

Representatives with Golmate Enterprise Limited (https://golmate.com/) announced today that it will attend the second phase of the Canton Fair Oct. 23 – 27.

“A lot of our thermos will be exhibited,” said Xiao Ming Yang, spokesperson for Golmate Enterprise Limited. “The booth No. is 6.1 J23.”

China Import and Export Fair, also known as the Canton Fair, is held biannually in Guangzhou every spring and autumn since 1957. The trade fair has the longest history, the largest scale, the most complete exhibit variety, and a wide spectrum of overseas buyers.

With more than 15 years of experience, Golmate, according to Yang, is a key manufacturer and exporter of quality thermal ware, which include: thermos, vacuum flasks, mugs, water jars, coffee pots, airpots, and more.

China Import and Export Fair, also known as the Canton Fair, is held biannually in Guangzhou every spring and autumn, with a history of 55 years since 1957. The Fair is a comprehensive one with the longest history, the highest level, the largest scale, the most complete exhibit variety, the broadest distribution of overseas buyers and the greatest business turnover in China.

Golmate Enterprise Limited, which sets itself apart from others in the market by having products that can pass the BSCI, LFGB, FDA tests, sells its goods in European and South American countries through a variety of importers and retailers such as Kaufland, Aldi, Costco, Nicolas Gonzalez Oddone S.A.E.C.A and Casino International Merchandise Division Z. The company prides itself in its level of customer service by providing technical support from Golmate’s China office.

For more information, please visit: https://www.golmate.com/products/ and https://www.golmate.com/blog/

About Golmate Enterprise Limited

Golmate provides a full range of services to its customers. The company staff follows up the orders actively and ensure on-time delivery of thermalware.

Source: Golmate Enterprise Limited

For more information about us, please visit http://www.golmate.com/

Contact Info:
Name: Xiao Ming Yang
Organization: Glomate Enterprise Limited
Address: Room 508, Huide Business Tower, #102 Haoxian Road, Guangzhou Guangdong, China
Phone: +86 20 83831015

Source: http://marketersmedia.com/golmate-enterprise-limited-to-attend-the-2nd-phase-of-the-canton-fair/92571

Release ID: 92571

Chase, Bank of America, Wells Fargo and Square Reader: Credit Card Processing Rates Compared Merchant Services

Image: https://pressreleasejet.com/newsreleases/images/2015/chase-bank-of-america-wells-fargo-and-square-reader.jpg

DALLAS, TX – 30 Sep, 2015 – Merchant Resources compares its credit card merchant services to those of Square Reader, Wells Fargo Merchant Services, Chase Merchant Services and Bank of America Merchant Services. Merchant Services credit card processing rates save you much needed money. You don’t have to pay for an expensive machine or point of sale system.

After Merchant Resources called the 1-800 listed on each of these merchant services, a variety of differences and cost of each of these credit card merchant services have been discovered. The compilation below:

Square Reader

• Base Retail Visa/MC rate of 2.75% • Key Entered Rate of 3.5%

The square reader rates are extremely high, especially if your average ticket is over fifty dollars.


Wells Fargo

• Base Retail Visa/MC rate of 1.8% • Lease of terminal for $35 a month or purchase terminal for $500 • $75 yearly fee

Merchant Resources has been in the business for over 20 years, knowing “for a fact” that the rate, no matter what the card is, is NOT 1.8%. It seems Wells Fargo has to train their merchant services department what the actual fees are.


Bank of America

• Base Retail Visa/MC rate of 1.69% • Rewards Cards Visa/MC rate of 3.19% • Business Cards Visa/MC rate of 4.35% and 29 cents • Foreign and Government Cards Visa/MC 4.35% and 29 cents • Cost of the terminal is %99 or a $28.95 per month • Three year contract


Chase Paymentech

• Base Retail Visa/MC rate of 1.99% and 25 cents • Mid qualified rate of 2.68% and 25 cents • Non qualified rate of 3.76% and 25 cents • $100 fee to get setup • $25 monthly minimum • Monthly fee of $9.95 • Free terminal with a 2 year contract


Merchant Resources offers the following:

• 1.25% for debit/credit card with no pin • 1.65% for base Visa and MasterCard, Discover • No Monthly Fees • FREE EMV Terminal with Pin Pad, Swiper for your cellular phone, or POS for restaurant

Merchant Resources offers custom quotes to fit your particular business.

To receive a free no obligation merchant account quote, visit http://www.credit-card-processing.com or call 1-888-895-3129

Full News Story: https://pressreleasejet.com/newsreleases/2015/chase-bank-of-america-wells-fargo-and-square-reader-credit-card-processing-rates-compared-merchant-services/

Distributed by Press Release Jet

Media Contact
Company Name: Merchant Resources
Contact Person: Jim Johnston
Email: info@merchantspecial.com
Phone: (888) 895-3129
Country: United States
Website: http://www.credit-card-processing.com

ReleaseID: 515116


Source: GetNews

Rexahn’s Human Data Confirms Anti-Cancer Advantage

NEW YORK, NY / ACCESSWIRE / September 30, 2015 / New results shown at last week’s European Cancer Congress (ECC) supported evidence that RX-3117 and Supinoxin, developed by Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), work well in humans – a big step up from preclinical data in mice. Phase Ib studies conducted the past year where safety and tolerance were observed mirrored animal trials, but the best news is efficacy in people, confirming Rexahn’s theory that its drugs’ mechanisms of action pinpoint crucial biological pathways in cancer progression.

Cancer-ridding programs at Rexahn, three in total in human trials, have a common goal: targeting tumors at a molecular level. Essential to this goal is tumor shrinkage or dealing a death blow through apoptosis, known as programmed cell death. Targeted cancer therapy has been applauded by oncologist researchers for its ability to potentially enhance efficacy and reduce bad side effects. Until Rexahn’s compounds, success has been spotty. More on that later.

Supinoxin and RX-3117 were previously tested in mice and results shown at two top cancer meetings last spring. Data strongly suggested the ability to prevent metastasis in certain cancer cell lines with no adverse events, setting the stage for human trials.

At ECC, Rexahn fulfilled its promise that Supinoxin works and is well tolerated: use of the drug alone stopped cancer cold in 13% of patients for over one year. Researchers involved in the Phase 1b study demonstrated belief that Rexahn discovered a new pathway key in cancer cell growth and dispersal, and that its ingenuity would be invaluable to treat this insidious disease.

Previously named RX-5902 and trademarked Supinoxin, it inhibits p-p68 RNA helicase, an enzyme working genetically to stop excessive cancer cell growth leading to solid tumor shrinkage, with preclinical activity in over a dozen cell lines.

Years earlier, p-p68 was associated with abnormal cell proliferation and the spread of neoplastic disease. Rexahn’s results repeat this research, lending strong testimony to Supinoxin’s mechanism of action against cancer.

Researchers were also encouraged by Supinoxin’s ability to exert its positive action and leave the body with sustained therapeutic success and no bad side effects – termed a pharmacokinetic profile – pointing to a good outcome of any oral medication. A call for more trials at a higher dose was recommended.

In another breakthrough moment for Rexahn’s oral drugs, efficacy in solid tumors using RX-3117 was found in Phase Ib and presented at ECC. The drug was, like Supinoxin, shown to be safe, tolerable, and had good pharmacokinetic findings. RX-3117 is a bioequivalent of cytidine (a biological component of our body’s RNA) that aims attacks at tumors through DNA synthesis to disrupt the metabolism of cancer and cause its demise.

In the Phase Ib trial using RX-3117, there was evidence of tumor reduction and stability of disease that lasted 276 days. With anti-tumor action clearly noted, more trials are planned. An important point, data built up over time and continuation of good results could prompt interest in Rexahn’s drugs in gemcitabine-resistant cancers.

Rexahn was granted Orphan Drug status for RX-3117 in pancreatic cancer when preclinical study researchers published results showing RX-3117 has anti-tumor power over gemcitabine (see graph below), once marketed as Gemzar and created by Eli Lilly & Co. (NYSE:LLY) before going generic. Gemcitabine is widely used in pancreatic cancer but with problems – up to 40% of patients develop resistance within one month and side effects can be severe, such as trouble breathing and swallowing, rash, fever, and blisters around the mouth.

Of those resistant, alternatives are few because cancer becomes aggressive and harder to treat after exposure to gemcitabine. Fulfirinox, an acronym for four chemotherapies, has been recommended despite great toxicity that works in a small percentage of patients and may cause peripheral nerve damage.

Rexahn has not announced pancreatic cancer the target for either of its drugs, but past efforts in this disease and achievement of a coveted FDA designation lead me to believe this cancer indication will reap the first benefits of RX-3117’s healing properties.

Both Phase Ib trials concluded with a recommendation to continue testing solid tumor patients at more frequent dosages until a maximum tolerated dose is found. So far, adverse side effects are mild – fatigue, stomach upset, and thirst.

Concerning competition, from past conversations Dr. Suzdak and I agree that certain forms of immunotherapy like PD-1 inhibitors and CAR-T cell therapy, for all their fanfare, are not scalable from a manufacturing standpoint; they must be customized per patient, causing the FDA trouble when blessing a plant with Good Manufacturing Practices (GMP) necessary to produce product for future clinical trials. Reimbursement could be problematic for coding procedures. Despite their popularity, only a fraction of patients respond. Side effects are not, in many cases, unlike standard chemotherapy with added risks of rapid and unexpected drops in blood pressure and organ inflammation.

Targeted therapies come in different guises, the more well-known and widely used include Herceptin for breast cancer, Erbitux for colorectal and lung cancer, Avastin for kidney cancer, Nexavar for liver cancer, and Tarceva for non-small cell lung cancer. Though scientists expected targeted drugs to be less toxic than traditional chemotherapy because cancer cells are more dependent on their targets than normal cells, the opposite is often true. Side effects are nasty: In general, blood clots develop and wounds heal much slower. Hepatitis is common. Dermatological problems abound – acne-like rash, excessive dryness of skin and graying of hair.

Herceptin can damage the heart. Erbitux causes swelling and cracks in skin. Avastin may lead to convulsions. Nexavar has been associated with hepatitis and bowel perforation. Patients on Tarceva may experience stabbing chest pains and the inability to speak. Despite these drawbacks, the market for oncology drugs worldwide is expected to reach $111.9 billion in 2020, with targeted therapies dominating.

Oncology medicine is ripe for a new answer, combining all the benefits of targeted cancer therapy like blocking progress of cancer from interference with tumor growth without fear of killing patients, as has been the case with Herceptin, made by Roche Holding AG (OTCQX: RHHBY) with a death count of 260 people or Avastin, another potentially dangerous offering by Roche that carries a 50% higher risk of death than using standard chemotherapy alone. Oncologists should welcome Rexahn’s drugs with their limited side effect profile and, as preliminary data shows, effectiveness.

Specific risks to an investment in Rexahn fall into the category of any targeted cancer therapy: cancer cells may develop resistance through mutation or find a new biochemical pathway to propagate tumor growth. A larger number of subjects could begin to show the onerous side effects seen with current targeted therapies. Phase 1b trials for RX-3117 and Supinoxin had a limited number of patients where results may not translate to later, bigger studies. Higher dosing of Supinoxin and RX-3117 may not produce desired effects and more adverse side effects may be seen, making Rexahn’s drugs not much better than existing targeted therapies or chemotherapy.

Given a cash position of $25.9 million as of 2Q2015 (ended June 30) plus an annualized burn rate of approximately $19 million and bigger clinical trials coming if smaller ones are successful, Rexahn will need to return to the market for further funding. As with most small-capitalization stocks, Rexahn may not actively trade or generate sufficient news flow, although its developing clinical programs should produce plenty of press. Competition, especially with immunotherapies, is strong and building, and may yield more positive results than those hindering this drug class in the past.

Rexahn’s non-toxic targeted tumor therapy with strong results should capture investor attention, particularly those looking to diversity past various overvalued immunotherapies and trumped-up targeted cancer drugs. Rexahn’s data has been viewed by thousands of ECC participants, from scientists to hopeful corporate partners. It’s time to see that Rexahn’s low valuation, in light of huge potential, makes it a bargain at current prices.

About Small Cap Forecasting, Inc.

Sharon di Stefano has spent 20 years as an analyst, beginning her career at Smith Barney, Harris Upham & Co. specializing in medical devices, pharmaceuticals, healthcare information technology, and bio-pharmacology. Ms. di Stefano had also served as Senior Venture Officer for the Edison Innovation Fund, implemented through the New Jersey Economic Development Authority that provided funding for early-stage life sciences companies. Industry experience includes laboratory research for Johns Hopkins Hospital and the Department of Defense. Ms. di Stefano received a Master’s of Science degree, in Business, from Johns Hopkins University in 1986, and a Bachelor of Arts from the University of Delaware in 1984 with a minor in biology.

Media contact:

Jackie Rodriguez
646-430-5783

SOURCE: Small Cap Forecasting, Inc.

ReleaseID: 432311

PeerLogix Appoints Chief Accounting Officer

Charles Gonsher Joins from Google Ventures

NEW YORK, NY / ACCESSWIRE / September 30, 2015 / PeerLogix, Inc. (the “Company”) (OTCQB: LOGX), an advertising technology and data aggregation provider, has hired Charles Gonsher as its Chief Accounting Officer. Mr. Gonsher’s appointment is crucial to the PeerLogix team, as the Company expects to launch its proprietary software as a service, or SAAS, platform and become revenue generating over the next few months. PeerLogix’ SAAS platform will enable the tracking and cataloguing of Torrent files and Torrent networks in order to determine consumer trends and preferences based upon media consumption.

Charles Gonsher joins from Google Ventures, after two and a half years on its venture capital finance team. Mr. Gonsher managed a team of analysts in geocommerce financial operations activity for the purposes of seed, growth and venture funding on behalf of Google’s investments in technology startups across the United States and internationally.

William Gorfein, Co-founder and CEO of PeerLogix, stated, “We are very excited to Charles join our team. We believe now is the right time for us create an experienced and capable financial team, as we transition to becoming a revenue generating company. Charles’ recent experience at Google Ventures adds a strategic component to our team with his knowledge and ability for investments, financings and acquisitions. We welcome Charles to the PeerLogix team and being part of a company helping the entertainment world connect with the content-sharing community.”

Charles Gonsher, Chief Accounting Officer, stated, “I am eager to provide PeerLogix with my financial acumen as they transition to being a publicly traded company. As PeerLogix continues to evolve into a global diversified digital media company, having a strong financial backbone is critical to achieving overall growth objectives in the present and beyond. Through our position on bringing swift change to the Torrent media marketplace and looking ahead to commercialization of the software platform next month, my efforts will be focused on generating revenue and introducing an extremely viable product to the geocommerce sector of the technology industry. I am excited to be a part of a Company so innovative in their vision and take pride not only in our team, but am also confident in the upwards trajectory of PeerLogix.”

About PeerLogix

PeerLogix is an advertising technology and data aggregation company providing a proprietary software as a service, or SAAS, platform which enables the tracking and cataloguing of Torrent files and Torrent networks in order to determine consumer trends and preferences based upon media consumption. PeerLogix’s patent pending platform collects Torrent data, including IP addresses of the uploading and downloading parties (e.g., location), the name, file type, media type (whether movie, television, documentary, music, e-books, software, etc.), and genre of media downloaded, and utilizes licensed and publicly available demographic and other databases to further filter the collected data to provide insights into consumer preferences to digital advertising firms, product and media companies, entertainment studios and others.

Torrent is a geography agnostic platform used by approximately 130 million people worldwide to share TV shows, movies, music, pictures, video games, e-books and software with one another. All major entertainment and media content is available to consumers using Torrent to access media. Of this population of Torrent users, approximately 40 million reside in the United States and 90 million are distributed throughout all major and developing countries of the world.

Forward Looking Statement

Certain of the statements contained in this herein include future expectations, contain projections of results of operations or financial condition or state other “forward-looking” information. The information contained in this includes some statements that are not purely historical and contain “forward-looking statements,” as defined by the Private Securities Litigation Reform Act of 1995,that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements regarding the Company’s and its management’s expectations, hopes, beliefs, intentions or strategies regarding the future, including the Company’s financial condition and results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “should,” “could,” “will,” “plan,” “future,” “continue,” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, the actual results could differ materially from the forward-looking statements contained in PeerLogix forward-looking statements.

Contact:

William Gorfein
Chief Executive Officer
PeerLogix, Inc.
646-598-4640
info@peerlogix.com

SOURCE: PeerLogix, Inc.

ReleaseID: 432310

Airwheel Z3 Self-Balancing 2 wheels scooters is a perfect combination of humanization and innovation

On new product release conference on 29th, September 2015, Airwheel Technology has launched four latest products: S6, F3, M3 and Z3. Followed by A3 and S5 launched on 18th, June 2015, only three months passed, there are new products released by Airwheel Technology. Its research and development department keeps innovative design to better meet the needs of various people. Also, Airwheel Z3 is one of them.

Airwheel Technology has launched four latest products: S6, F3, M3 and Z3 on new product release conference on 29th, September 2015. Followed by A3 and S5 launched on 18th, June, only three months passed, there are new products released by Airwheel Technology. Its research and development department keeps innovative design to better meet the needs of various people. Also, Airwheel Z3 electric motor is one of them. For more comfortable and enjoyable riding experience, there are many humanized design on Z3.

Image: http://www.airwheel.net/scooters/Airwheel_Z3_1.jpg

First, the human design of Z3 will be introduced. With the anterior standing design, Airwheel Z3 scooter electric accords with principles of ergonomics, and changes the side standing which easily cause fatigue. On the other hand, adjustable operating arm, it can be adjusted according to the height of the riders to provide the most comfortable riding experience. Pedal made from matting material has great skid resistance; it is safe without hidden trouble and can improve the operation.

Image: http://www.airwheel.net/scooters/Airwheel_Z3_2.jpg

Moreover, Airwheel Z3 two-wheeled electric scooter is mounted with changeable battery pack, which is imported battery. Riders will never be worried about running out of electricity. With the up-equipped battery design, Z3 will be with you rain or shine which suitable for all weather conditions and road conditions.

Besides, there are many innovative designs on Z3. The innovative multiple fold system, makes Z3 electric scooter easy to put. The tire size is only 8 inch with the maximum load of 100kg. The body is made of aluminium material, solid and fashionable. Brake assist system is adopted to Airwheel Z3 electric scooter. When there is emergency braking, riders can Increase the brake force to shorten braking distance. With the Intelligent security tail lights system, it brings not only the attention, but also safety.

All in all, the Airwheel Z3 self-balancing 2 wheels scooter shows a perfect combination of humanization and innovation.

Media Contact
Company Name: Airwheel Technology Holding (USA) Co., Ltd.
Contact Person: Mr. Tang
Email: business@airwheel.net
Phone: +8618861270200
City: LA
State: CA
Country: United States
Website: http://www.airwheel.net/

Source: ABNewswire

ReleaseID: 38888

The Mini Toy-Airwheel personal transportation mini Electric Self-balancing Scooter S6 Shows up on New Product Release Conference

Nowadays, many things are becoming smaller and smaller. Airwheel Technology follows such trend and has released the latest product – Airwheel S6 which belongs to the mini one in S series. As the fan of Airwheel, there is no doubt that, it is a great news. Airwheel electric self-balancing scooter S6 shows up on new product release conference on 29th, September 2015. Today,
It is very luck for people to have a first look at the stylish and shining Airwheel S6.

Though continuous efforts of Airwheel Technology, it has released the latest product – Airwheel S6 which belongs to the mini one in S series. As the fan of Airwheel, there is no doubt that, it is a great news. Airwheel S6 sitting posture self-balancing scooter shows up on new product release conference on 29th, September 2015. Today, it is very luck for people to have a first look at the stylish and shining Airwheel S6. The detailed improvements will be the highlights of Airwheel S6 self-balancing scooter.

Image: http://www.airwheel.net/scooters/Airwheel_S6_1.jpg

Compared with the Airwheel S3, S3T and S5, there are some improvements in Airwheel S6 mini electric scooter. First, the tiny size appeals people most. The diameter centimetre of the mini wheel is only 20cm. Besides, the main structure is made of magnesium alloy. It is light and handy, which can easily be put into your trunk. Secondly, equipped with low underpan, it lowers the centres of gravity, so that the vehicle can runs more smoothly and steadily. Thirdly, with double-balanced precision sensors, it can be more intelligent than the former electric scooters. Sensitivity increased greatly, Airwheel S6 can react kinds of emergencies more quickly.

Image: http://www.airwheel.net/scooters/Airwheel_S6_2.jpg

With more humanized design, Airwheel S6 mini self-balancing scooter is adopted the adjustable seat cushion, so that the riders can have posture that is more graceful. More importantly, the riders can sit or stand on it. The manipulation of Airwheel S6 is different from others by leaning forward or backward to proceed or go hack. People control it by horizontal rotation. It is much easier for people to ride with the speed of 17 km/h.

Appearance designed with science and technology, Airwheel S6 mini self-balancing scooter will leave people a deep first impression and definitely will cause a buying spree in the whole world.

Media Contact
Company Name: Airwheel Technology Holding (USA) Co., Ltd.
Contact Person: Mr. Tang
Email: business@airwheel.net
Phone: +8618861270200
City: LA
State: CA
Country: United States
Website: http://www.airwheel.net/

Source: ABNewswire

ReleaseID: 38887